Living Well With Uncertainty in Advanced, Metastatic or Incurable Cancers: A Pragmatic Feasibility Study of the Adapting to Life With Cancer Cognitive ExisteNtial Therapy (ACCENT)
Psychooncology. 2025 Apr;34(4):e70140. doi: 10.1002/pon.70140. ABSTRACT BACKGROUND: New treatments are contributing to individuals living longer with advanced, metastatic, or incurable (AMI) cancers. The impact of these treatments is unpredictable, resulting…
Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial
Lancet Glob Health. 2025 Apr;13(4):e707-e715. doi: 10.1016/S2214-109X(24)00527-8. ABSTRACT BACKGROUND: Secondary antibiotic prophylaxis is the only intervention known to prevent rheumatic heart disease progression, yet delivery of prophylaxis at scale in…
Living Well With Uncertainty in Advanced, Metastatic or Incurable Cancers: A Pragmatic Feasibility Study of the Adapting to Life With Cancer Cognitive ExisteNtial Therapy (ACCENT)
Psychooncology. 2025 Apr;34(4):e70140. doi: 10.1002/pon.70140. ABSTRACT BACKGROUND: New treatments are contributing to individuals living longer with advanced, metastatic, or incurable (AMI) cancers. The impact of these treatments is unpredictable, resulting…
Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial
Lancet Glob Health. 2025 Apr;13(4):e707-e715. doi: 10.1016/S2214-109X(24)00527-8. ABSTRACT BACKGROUND: Secondary antibiotic prophylaxis is the only intervention known to prevent rheumatic heart disease progression, yet delivery of prophylaxis at scale in…
Living Well With Uncertainty in Advanced, Metastatic or Incurable Cancers: A Pragmatic Feasibility Study of the Adapting to Life With Cancer Cognitive ExisteNtial Therapy (ACCENT)
Psychooncology. 2025 Apr;34(4):e70140. doi: 10.1002/pon.70140. ABSTRACT BACKGROUND: New treatments are contributing to individuals living longer with advanced, metastatic, or incurable (AMI) cancers. The impact of these treatments is unpredictable, resulting…
Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial
Lancet Glob Health. 2025 Apr;13(4):e707-e715. doi: 10.1016/S2214-109X(24)00527-8. ABSTRACT BACKGROUND: Secondary antibiotic prophylaxis is the only intervention known to prevent rheumatic heart disease progression, yet delivery of prophylaxis at scale in…
Living Well With Uncertainty in Advanced, Metastatic or Incurable Cancers: A Pragmatic Feasibility Study of the Adapting to Life With Cancer Cognitive ExisteNtial Therapy (ACCENT)
Psychooncology. 2025 Apr;34(4):e70140. doi: 10.1002/pon.70140. ABSTRACT BACKGROUND: New treatments are contributing to individuals living longer with advanced, metastatic, or incurable (AMI) cancers. The impact of these treatments is unpredictable, resulting…
Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial
Lancet Glob Health. 2025 Apr;13(4):e707-e715. doi: 10.1016/S2214-109X(24)00527-8. ABSTRACT BACKGROUND: Secondary antibiotic prophylaxis is the only intervention known to prevent rheumatic heart disease progression, yet delivery of prophylaxis at scale in…
Living Well With Uncertainty in Advanced, Metastatic or Incurable Cancers: A Pragmatic Feasibility Study of the Adapting to Life With Cancer Cognitive ExisteNtial Therapy (ACCENT)
Psychooncology. 2025 Apr;34(4):e70140. doi: 10.1002/pon.70140. ABSTRACT BACKGROUND: New treatments are contributing to individuals living longer with advanced, metastatic, or incurable (AMI) cancers. The impact of these treatments is unpredictable, resulting…
Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial
Lancet Glob Health. 2025 Apr;13(4):e707-e715. doi: 10.1016/S2214-109X(24)00527-8. ABSTRACT BACKGROUND: Secondary antibiotic prophylaxis is the only intervention known to prevent rheumatic heart disease progression, yet delivery of prophylaxis at scale in…
